Search results
Results from the WOW.Com Content Network
Jakafi can cause serious side effects including: Low blood counts: Jakafi may cause your platelet, red blood cell, or white blood cell counts to be lowered. If you develop bleeding, stop taking ...
According to the U.S. Centers for Disease Control and Prevention, while "any vaccine can cause side effects", [11] most side effects are minor, primarily including sore arms or a mild fever. [11] Unlike most medical interventions vaccines are given to healthy people, where the risk of side effects is not as easily outweighed by the benefit of ...
As with all medications, vaccines are continually monitored for safety, and like any medication, vaccines can cause side effects. The side effects of vaccination are typically minor and go away within a few days. There is a risk that the child could have a severe allergic reaction, but these reactions are rare.
Vaccines are recommended for most people starting before their 15th birthday in two doses, but children can get it starting at age 9. Research suggests a first dose around 9 years old provides ...
Japanese encephalitis vaccine is a vaccine that protects against Japanese encephalitis. [2] The vaccines are more than 90% effective. [2] The duration of protection with the vaccine is not clear but its effectiveness appears to decrease over time. [2] Doses are given either by injection into a muscle or just under the skin. [2]
Having side effects after getting a COVID-19 vaccine are a sign that your immune system is responding, experts say.
Ruxolitinib (sold under the brand names Jakafi and Jakavi among others, and as Opzelura in cream form) is a medication used for the treatment of intermediate or high-risk myelofibrosis, [6] a type of myeloproliferative neoplasm that affects the bone marrow; [11] [12] polycythemia vera, when there has been an inadequate response to or intolerance of hydroxyurea; [6] [13] and steroid-refractory ...
The hypothesis that vaccines have non-specific effects was formulated in the early 1990s by Peter Aaby at the Bandim Health Project in West Africa. [4] The first indication of the importance of the non-specific effects of vaccines came in a series of randomized controlled trials (RCTs) in the late 1980s.